While invasive angiography and quantitative flow ratio (QFR) are gold standards for diagnosing coronary functional ischemia, they primarily reflect focal anatomical hemodynamics and fail to capture the systemic metabolic vulnerability of the patient. We aimed to develop and rigorously validate a noninvasive predi...
M. Bao, W. Dai, R. Guo et al.· European Heart Journal· 0 citations
Aspirin is the cornerstone of antiplatelet therapy for non-ST-elevation myocardial infarction (NSTEMI), while indobufen serves as an alternative for patients with aspirin intolerance. However, comparative data on their long-term efficacy and safety in real-world NSTEMI populations are limited.
This study a...
H. Zhang, S.-T. Hu, R. Guo et al.· European Heart Journal· 0 citations
The optimal low-density lipoprotein cholesterol (LDL-c) target after acute myocardial infarction (AMI) in patients with prior ischemic stroke remains uncertain, particularly regarding the trade-off between ischemic protection and bleeding risk. We evaluated the association between LDL-c levels achieved at three m...
Y.-K. Zhang, R.-X. Guo, Z. Xue et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.